| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |